Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
← Back to archive
2022 Michigan Affirmative

Aff - Information Warfare Addendum - Michigan Classic 2022 HJV

Aff - Information Warfare Addendum - Michigan Classic 2022 HJV.docx

Download Word file
Indexed text preview
Aff Addendum
**Vaccines**
2AC Vaccines Add-On
China and Russia use information warfare exploit pandemics and slow foreign response
Bachmann et al 20 – [Sascha-Dominik Dov Bachmann, Doowan Lee, and Andrew Dowse; Sascha-Dominik Dov Bachmann - Canberra Law School; NATO SHAPE; Swedish Defence University (FHS). Doowan Lee - Government of the United States of America - Naval Postgraduate School. Andrew Dowse - Edith Cowan University. “COVID Information Warfare and the Future of Great Power Competition,” The Fletcher Forum of World Affairs Vol.44:2 Summer 2020, 11-16-2020, accessed through SSRN.]
COVID-19 AND GREAT POWER COMPETITION COVID-19 (or coronavirus) has ushered in a new era of heightened competition among major powers. The pandemic’s impact has far exceeded national security and public health. In addition to COVID-19 as a global health emergency, we see increasing weaponization1 of the pandemic by both the Kremlin and the CCP to achieve strategic goals. Unfortunately, our own resilience to oppose such aggressive acts remains under-matched. One of the key components of the CCP’s strategy concerns operations in the information sphere, per the so-called ‘Three Warfares’2 which is discussed later in the article. Below the threshold of armed conflict and taking place in the ‘grey zone’, such information operations manifest as either influence operations and/or ‘strategic preconditioning’3 for any later action, both with and without the use of force.
INFORMATION WARFARE DURING COVID-19 Great Power competition of today is evident in Western relations with both the Kremlin and the CCP. The CCP appears determined to shape the world to a strategic vision where it will safeguard its economic, strategic, and security interests in Asia, the Pacific, Europe, and the Arctic for generations to come.4 Russia—its strategic partner—aims to rebuild Russia as a ‘Great Power’ and player on the international scene with twin foci on Europe and on where opportunities may arise for it to weaken Western influence and interests. It should be noted that both the Kremlin and the CCP are using concepts which we describe as either hybrid warfare and/or grey-zone warfare, examples of which are best provided by contemporary Russian warfare approaches.5 Responding to the use of irregular strategies employed by the CCP and the Kremlin, the U.S. has included the concept of Great Power competition in its national security strategy. Great Power competition entails the distribution of relative gains with no finite terminal objectives. In this context, it is not hard to see how information warfare plays a critical role in shaping how the great powers are competing in key issue areas where major powers use weaponized narratives to sow internal discord and distrust,6 rendering their adversaries unable to focus on external threats. In other words, the information environment has thus become one of the main battle spaces of Great Power competition. The need to approach information warfare from a full-spectrum perspective is more acute than ever. While disinformation mitigation is a critical component of information statecraft, it is only a necessary component, not the sufficient whole. Both revisionist states use digital media platforms and other information warfare capabilities not only to consolidate their authoritarian rule, but also to undermine and disrupt the liberal international order that the United States and its allies have buttressed.7 Drawing on this inspiration, other autocrats are emulating the CCP and the Kremlin to exploit the information environment and undermine the strategic interests of the United States.8 Authoritarian regimes further seem determined to weaponize digital media and information technology from domestic population control mechanisms to foreign policy tools.9 Emulating the Kremlin, the CCP seems poised to weaponize the cyber domain, as well as publicly available information (PAI) as tools of disruption and coercion.10 For example, the CCP has aggressively promoted patently false narratives about the origin of the coronavirus. In addition, it has actively promoted the Party’s public health ‘leadership’ using automated accounts, bots, and trolls, despite numerous frauds and defects noticed in several countries.11 The CCP’s COVID aid to other countries has further been riddled with frauds, to say nothing of its explicit use for propaganda purposes.12 Similarly, the Kremlin is exploiting the pandemic to highlight how the European Union is failing its mandates.13 While this is consistent with the Kremlin’s information operations as we saw in the 2016 election, it has palpably escalated its propaganda efforts during the COVID pandemic by intentionally propping up radical right conversations that promote the dissolution of the EU
Foreign disinformation campaigns decrease vaccination rates. We need to implement the plan now
Wilson and Wiysonge 2020 — [Steven Lloyd Wilson and Charles Wiysonge - politics, Brandeis University, Waltham, Massachusetts, USA and Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa, “Social media and vaccine hesitancy,” BMJ Global Health, 11-17-2020 https://gh.bmj.com/content/5/10/e004206.full, accessed 7-21-2022]
Meaning of the study Foreign disinformation campaigns are robustly associated with declines in mean vaccination rates. The use of social media to organise offline action is highly associated with an increase in public belief in vaccines being unsafe. Both of these findings suggest that combating disinformation and misinformation regarding vaccines online is critical to reversing the growth in vaccine hesitancy around the world. These findings are especially salient in the context of the COVID-19 pandemic, given that the vaccines under development will require deployment globally to billions of people in the next year. Policymakers need to begin planning now for ways to work against the patterns found in this study. While public outreach and education about the importance of vaccines will likely be the cornerstone of any COVID-19 vaccine deployment, we argue that the findings in this paper show that such efforts are empirically not sufficient even if clearly necessary. Based on our findings, we argue for an additional two-pronged strategy explicitly targeting foreign disinformation campaigns and the use of social media by anti-vaccination groups. First, governments must mandate that social media companies are responsible for taking down antivaccination content (whether originating from genuine domestic actors or foreign propaganda operations). This is obviously easier said than done and involves both legal and technical hurdles. However, authoritarian states provide an ironic roadmap despite the chilling implications for free speech: they have consistently been successful at pressing technology companies into policing speech on their behalf within their borders. Where there is political will, there is the capacity for removing content damaging public health. Second, foreign disinformation campaigns should be addressed at their source. A preponderance of such campaigns amplifying anti-vaccination content originate from within Russia or via pseudo-state actors informally associated with Russia. The utilisation of information warfare on the internet is a broad issue that has little hope of general resolution. However, given the global nature of the COVID-19 crisis and the fact that pushing anti-vaccination propaganda will tangibly cause civilian deaths around the world—and in Russia—there is a chance that, with sufficient pressure and incentivisation, diplomacy could produce a ceasefire of sorts with regard to this specific genre of disinformation. We urge policymakers to take the time before a COVID-19 vaccine is available for mass distribution as an opportunity for action against social media factors contributing to vaccine hesitancy.
Specifically, misinformation about vaccines cause vaccine hesitancy – studies prove
Garett and Young ’21 — [Renee Garett; 1ElevateU, Irvine, CA, USA. 2Department of Emergency Medicine, University of California, Irvine, CA 92697, USA.3University of California Institute for Prediction Technology, Department of Informatics, University of California, Irvine, CA, USA, Sean D. Young; University of California Institute for Prediction Technology, Department of Family Medicine, University of California, Los Angeles, 10880 Wilshire Blvd., Ste. 1800, Los Angeles, CA, 90024, USA “Online misinformation and vaccine hesitancy,” OUP Academic, 9-16-2021, https://academic.oup.com/tbm/article/11/12/2194/6371221?login=false, accessed 7-10-2022]
Online misinformation on websites can also negatively impact people’s willingness to take vaccines. According to the Pew Research Center, 55% of Americans with access to the internet sought health or medical information online with some reporting that the information they obtained influenced their health behaviors. Unfortunately, content on health websites varies in accuracy and quality with approximately 6% of those examined containing incorrect information [21]. Anti-vaccination websites take many forms from activism to natural health sites to general news and blogging sites, with some sites receiving 1.5 million unique visitors per month [22]. This is unsurprising since researchers found that 43% of websites propagated during a web search for “vaccination” and “immunization” comprised of anti-vaccination websites [15]. Once led to websites, readers may be bombarded with information that questions scientific integrity, use emotive appeals for civil liberties, and concern for the health and welfare of children. Anti-vaccination persuasion centers on creating a community affected by vaccines and vaccine-related practices [23]. Main themes used by anti-vaccine champions include safety and effectiveness, alternative medicine, freedom and rights, conspiracy theories, and morality [14].
SOCIAL MEDIA
One of the most efficient methods of spreading vaccine misinformation online is through social media. A report by the Centre for Countering Digital Hate (CCDH) found that social media accounts by anti-vaccination proponents gained 7.8 million followers since 2019, with 31 million Facebook users following anti-vaccination accounts and 17 million YouTube users subscribing to similar accounts [24]. In examining vaccine chatter on Facebook, researchers found that though anti-vaccination clusters were fewer in numbers than pro-vaccination clusters, they nevertheless had very high presence and were well entangled with undecided clusters [25]. One study found that public use of social media to organize action was associated with the belief that vaccines were unsafe and that foreign disinformation campaigns on social media were associated with lower vaccination rates and negative discourse/posts on social media [26]. Another study examined coverage of the human papilloma virus (HPV) vaccine in social media and state-level HPV vaccine coverage. Results showed that exposure to information on social media explained a higher proportion of the variance in vaccine coverage compared to socioeconomic factors, and that vaccine coverage was lower in states with higher exposure to misinformation, conspiracy theories, and safety concerns [27].
COVID-19 VACCINE-RELATED MISINFORMATION
During the current COVID-19 pandemic, it is especially important to be aware of the prevalence and role that online misinformation is having on people’s attitudes and behaviors as this affects willingness to get the COVID-19 vaccine. News of the availability and near dissemination of the recently developed and tested vaccines began to circulate in headlines and social media posts. Subsequently, misinformation and conspiracies about the COVID-19 vaccine gained traction [28, 29]. Investigators who examined media consumption and reliance on specific institutions regarding COVID-19 found that reliance on certain news formats and sources was associated with knowledge, misinformation, and prejudice [30]. The amount of misinformation online surrounding the vaccine has been labeled as a second pandemic and has fueled the mistrust surrounding the handling of the pandemic, which can undermine efforts to vaccinate [31]. Surveys of adults about getting the COVID-19 vaccine showed reluctance in doing so. The report by CCDH noted that one in six British would get vaccinated for COVID-19 [24] and an even higher number of Americans, four in ten, stated they definitely or probably would not get the COVID-19 vaccine [32]. In a randomized control study, participants who were exposed to snippets of social media posts containing COVID-19 misinformation had a decrease in intent to obtain the vaccine compared to controls who were exposed to factual COVID-19 information [33].
Vaccines are also crucial to stopping future pandemics—but reassuring the public about their safety is crucial:
Julie L. Gerberding, M.D., M.P.H., and Barton F. Haynes, M.D., 2/4/2021 (New England Journal of Medicine, “Vaccine Innovations — Past and Future,” https://www.nejm.org/doi/full/10.1056/nejmp2029466, Retrieved 8/2/2021)
Vaccination is a powerful method of disease prevention that is relevant to people of all ages and in all countries, as the Covid-19 pandemic illustrates. Vaccination can improve people’s chances of survival, protect communities from new and reemerging health threats, and enhance societal productivity. But achieving the promise of vaccination requires much more than the vaccines themselves. It requires appropriate incentives to encourage the timely discovery and development of innovative, effective, safe, and affordable products; effective financing and delivery programs; and credible scientific leaders who can provide evidence-based policy recommendations and reassure the public about the value of the vaccines. Since its inception 50 years ago, the National Academy of Medicine (NAM), previously known as the Institute of Medicine (IOM), has been an authoritative resource on medical issues, including vaccination, and a global leader in vaccine-policy development. FDA Licensure Dates for Selected Innovative Vaccines since 1970. It’s hard to overstate the benefits that innovative vaccines deployed in the past five decades have had on morbidity and mortality (see timeline).1 The incidence of vaccine-preventable diseases among U.S. children has decreased dramatically, an achievement that is attributable in part to high vaccine-coverage rates. By the 2018–2019 school year, coverage rates among kindergarteners exceeded 90% in all but two states, according to data from the Centers for Disease Control and Prevention (CDC). Four vaccine-preventable illnesses have been eliminated from the Americas: smallpox in 1971, poliomyelitis in 1994, and rubella and congenital rubella syndrome in 2015 (one of us is an executive vice president at Merck, which produces vaccines for rubella, among other vaccines). Moreover, between 2011 and 2020, immunization programs in low-income countries saved an estimated 23.3 million lives.2 Perhaps the most notable immunization-related accomplishment during the past half century was the eradication of smallpox, which was verified by the World Health Organization (WHO) in 1980. In addition, global cases of paralytic polio have decreased by 99.95% from the estimated 350,000 cases in 1988,3 when the global polio-eradication program was announced, and two of the three wild-type polioviruses, WPV types 2 and 3, have been eradicated. Other important achievements during this period include the 1986 approval of the first vaccine based on recombinant technology, a hepatitis B vaccine that not only has reduced rates of the infection in many countries but was also the first vaccine to reduce cancer risk. In 1987, the first polysaccharide-protein conjugate vaccine was licensed; since then, the incidence of invasive Haemophilus influenzae type b disease among children has fallen dramatically. In 2009, a vaccine for Neisseria meningitidis group A became the first licensed vaccine specifically designed for certain people in low-income countries. Achieving broad population health benefits associated with vaccination requires effective policies that create incentives for vaccine development, ensure financing of vaccines, and improve access. After a measles outbreak in 1989–1991, the U.S. Vaccines for Children Program was authorized in 1993 to ensure that eligible children would have free access to all CDC-recommended vaccines. To address remaining gaps, the IOM in 2000 issued a landmark report that recommended policy and programmatic improvements to strengthen U.S. immunization programs. One outcome of this effort was the requirement included in the 2010 Affordable Care Act that plans provide first-dollar coverage (coverage without copayments or other cost sharing) for vaccines recommended by the CDC’s Advisory Committee on Immunization Practices for children and adults up to age 26. Policy advances have also enhanced the effects of vaccination globally. The WHO launched the Expanded Program on Immunization in 1974 to increase access to vaccines. Beginning in 2000, the benefits of this program were greatly enhanced by the creation of Gavi, the Vaccine Alliance, an international public–private partnership that provides financial and programmatic support to ensure that children in the poorest countries have access to vaccines. In 2017, with the support of the NAM and other organizations, this model was used as a framework for the creation of the Coalition for Epidemic Preparedness Innovations to fund innovative vaccines and other countermeasures against pathogens that cause devastating public health consequences, such as the Ebola virus and now SARS-CoV-2. Because vaccines are usually administered to healthy people, maintaining the highest safety standards isn’t only an ethical imperative but is also essential to sustaining public trust. The story of vaccine progress has been punctuated by both real and misguided safety concerns for as long as vaccines have been in use. Such concerns have included adverse events associated with vaccination itself, quality lapses in the manufacturing process, and false alarms regarding vaccine safety. The potential for financial gain has fueled liability suits related to putative safety concerns. The NAM has conducted ongoing objective assessments of vaccine safety to help address concerns. Between 2000 and 2004, its Immunization Safety Review Committee evaluated evidence pertinent to various vaccine-safety topics and set a new standard for independent scientific review that remains relevant as the NAM contributes to coronavirus-related policies. Vaccine confidence depends on trust in the safety and efficacy of the products themselves, trust in vaccine manufacturers and the clinicians who administer vaccines, and trust in policymakers who assess the scientific evidence and promulgate vaccination recommendations. Failures in any of these areas can have substantial long-term public health consequences, as was the case with misinformation about measles vaccines. Enduring mistrust stemming from a discredited study that associated childhood vaccination with autism has been linked to recent outbreaks of measles in the United States. Sustaining both vaccine safety and trust in vaccination will become increasingly complex. Vaccines continue to be approved, and more vaccines have become accessible in resource-limited countries, but safety surveillance systems are less evolved in many low-income regions than in high-income regions. Similarly, vaccines are being manufactured in regions where regulatory oversight isn’t always optimal, and counterfeit vaccines remain a threat. Emerging infections may require rapid availability of new vaccines before comprehensive safety studies are complete. Perhaps most important, the speed and reach of communication on social media platfo

Preview shortened. Download the file for the full document.